| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/18/2002 | WO2002030963A1 Human ect2 and methods of use |
| 04/18/2002 | WO2002030952A2 Haplotypes of the cyp27a1 gene |
| 04/18/2002 | WO2002030951A2 Haplotypes of the cyp1b1 gene |
| 04/18/2002 | WO2002030950A2 Haplotypes of the fy gene |
| 04/18/2002 | WO2002030949A2 Haplotypes of the ltb4r gene |
| 04/18/2002 | WO2002030946A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 04/18/2002 | WO2002030944A2 Fluorescent nucleobase conjugates having anionic linkers |
| 04/18/2002 | WO2002030571A2 Surface adsorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces |
| 04/18/2002 | WO2002030561A2 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 04/18/2002 | WO2002030478A2 Detection of the presence of a microbe or related substance at a location |
| 04/18/2002 | WO2002030471A2 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030354A2 Uridine therapy for patients with elevated purine levels |
| 04/18/2002 | WO2002030268A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | WO2002030266A2 Detection of dna damage |
| 04/18/2002 | WO2002030256A2 Diagnostic indicator of thymic function |
| 04/18/2002 | WO2002010747A3 Method and apparatus for patch-clamp measurements on cells |
| 04/18/2002 | WO2002010432A3 Triphosphate oligonucleotide modification reagents and uses thereof |
| 04/18/2002 | WO2002008463A3 Collection of binding molecules |
| 04/18/2002 | WO2002008252A3 Novel protein containing ring finger domaine r1p4 |
| 04/18/2002 | WO2002006478A3 Extracellular matrix protein |
| 04/18/2002 | WO2002004596A3 Diagnosing and treating cancer cells using mutant viruses |
| 04/18/2002 | WO2002003919A3 Structural targets in hepatitis c virus ires element |
| 04/18/2002 | WO2002000915A3 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation |
| 04/18/2002 | WO2002000248A3 Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling |
| 04/18/2002 | WO2001098529A3 Method for detecting fungicides |
| 04/18/2002 | WO2001094611A3 Method and system for predicting nucleic acid hybridization thermodynamics and computer-readable storage medium for use therein |
| 04/18/2002 | WO2001094542A3 Algorithmic determination of connectrons |
| 04/18/2002 | WO2001090117A3 Haplotypes of the p2ry1 gene |
| 04/18/2002 | WO2001087768A3 Use of vapor-deposited conformal coatings in microfluidic structures |
| 04/18/2002 | WO2001085989A8 Hypha-specific factors from candida albicans |
| 04/18/2002 | WO2001085954A3 Serine-threonine kinase-3 |
| 04/18/2002 | WO2001085766A3 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001081409A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 04/18/2002 | WO2001080717A3 Methods and compositions for the diagnosis of schizophrenia |
| 04/18/2002 | WO2001075448A3 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen |
| 04/18/2002 | WO2001075151A3 Method for detecting macromolecular biopolymers by means of an electrode arrangement |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001068912A3 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 04/18/2002 | WO2001068897A3 Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals |
| 04/18/2002 | WO2001066803A3 Phytomics: a genomic-based approach to herbal compositions |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064876A3 Human schizophrenia gene |
| 04/18/2002 | WO2001064856A3 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 04/18/2002 | WO2001064833A3 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor |
| 04/18/2002 | WO2001063284A3 Internal standards and controls for multiplexed assay |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001060400A3 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/18/2002 | WO2001059457A3 Assay for detection of viral fusion inhibitors |
| 04/18/2002 | WO2001059159A3 Molecular biological kit apparatus and method |
| 04/18/2002 | WO2001057527A3 Process for the identification of igg-producing cells |
| 04/18/2002 | WO2001057258A3 Direct detection and mutation analysis of low copy number nucleic acids |
| 04/18/2002 | WO2001057257A3 Isolation and identification of mrnas correlating to secreted proteins |
| 04/18/2002 | WO2001057238A3 Electrochemical test strip for use in analyte determination |
| 04/18/2002 | WO2001053534A3 Method of identifying the function of a test agent |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001034789A3 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 04/18/2002 | WO2001031060A3 Identical-by-descent fragment enrichment |
| 04/18/2002 | WO2001027324A3 Converting diploidy to haploidy for genetic diagnosis |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2001025420A3 Adjustable sensitivity, genetic molecular interaction systems, including protein-protein interaction systems for detection and analysis |
| 04/18/2002 | WO2001023618A3 Compositions and methods for reducing oligonucleotide hybridization and priming specificity |
| 04/18/2002 | WO2001018245A3 Detection of alterations in a gene by long range pcr using human mobile elements |
| 04/18/2002 | WO2000073488A9 Plasmodium sp. chitinase |
| 04/18/2002 | WO2000071756A9 Mathematical analysis for the estimation of changes in the level of gene expression |
| 04/18/2002 | WO2000071752A9 Assay for the detection of paclitaxel resistant cells in human tumors |
| 04/18/2002 | WO2000071742A9 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics |
| 04/18/2002 | WO2000070341A9 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 04/18/2002 | WO2000070073A9 Method for sequencing nucleic acid molecules |
| 04/18/2002 | WO2000068411A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 04/18/2002 | WO2000058508A3 Biallelic markers related to genes involved in drug metabolism |
| 04/18/2002 | WO2000055192A3 Hemocyanin and nucleic acid sequence coding for the same |
| 04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
| 04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
| 04/18/2002 | US20020045739 Acyl glucosaminyl inositol amidase family and methods of use |
| 04/18/2002 | US20020045738 Oligonucleotide-binding e-tag probe compositions |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045592 Genes identified as required for proliferation in escherichia coli |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045564 Methods of modulating muscle contraction |
| 04/18/2002 | US20020045276 Analyte assay using particulate labels |
| 04/18/2002 | US20020045257 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells |
| 04/18/2002 | US20020045253 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines |
| 04/18/2002 | US20020045237 Bacterial two-hybrid system for protein-protein interaction screening, new strains for use therein, and their applications |
| 04/18/2002 | US20020045235 IKB kinase, subunits thereof, and methods of using same |
| 04/18/2002 | US20020045227 Method for detecting mutated alleles |
| 04/18/2002 | US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 04/18/2002 | US20020045208 Nucleotide sequences which code polypeptides for use in treatment of autoimmune diseases, allergies and tumors |
| 04/18/2002 | US20020045206 Contacting the cells with a trophic amount of a ptc therapeutic for promoting survival of substantia nigra neuronal cells |
| 04/18/2002 | US20020045203 Method for detecting active ingredients of medical value |
| 04/18/2002 | US20020045202 Enzymatic polypeptide for use in diagnosis, prevention and treatment of inflammatory defects, cancer, diabetes |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045197 Methods of determining protein activity levels using gene expression profiles |
| 04/18/2002 | US20020045194 Proteomic analysis |
| 04/18/2002 | US20020045188 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 04/18/2002 | US20020045185 Secreted neural adhesion proteins |